Controlled dangerous substances; authorizing certain scientific research and clinical trials related to psilocybin and psilocyn; requiring registration; providing certain immunities; effective date.
Bill status
passed
3 of 5 stages cleared
Introduction
Feb 2023
Committee Review
Mar 2023
House Passage
Mar 2023
Senate Passage
Governor
Introduced Feb 6, 2023
Last action Mar 29, 2023
Floor votes
How they voted
This bill passed the House by voice vote (no roll call recorded).
Full legislative history
Actions timeline
Total actions
16
Key actions
4
Committee
2
Amendments
1
Mar 13, 2023
Introduced
First Reading
upper
Mar 13, 2023
Lower · Passed
Engrossed, signed, to Senate
lower
Mar 9, 2023
Committee
Referred for engrossment
lower
Mar 9, 2023
Lower · Passed
Third Reading, Measure passed: Ayes: 66 Nays: 32
lower
Mar 9, 2023
Lower · Passed
Amended
lower
Feb 15, 2023
Lower · Passed
CR; Do Pass, amended by committee substitute Alcohol, Tobacco and Controlled Substances Committee
lower
Feb 6, 2023
Introduced
First Reading
lower
2 primary · 0 co-sponsors
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about HB 2107
Scope: OK
Hi! I can help you understand HB 2107. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline